Boehringer Ingelheim’s core principles and vision guide our work with patient organisations. Learn about how we collaborate with patient organisations.
Beyond direct support of the healthcare community on the ground, several organisations are receiving support in Southeast Asia & South Korea. Learn more.
COVID-19 Italy for isolated patients to keep contact
300 tablets donated to hospitals in Italy where patients isolated due to COVID-19 are fighting for recovery to let them feel less alone. Learn more here.
Boehringer Ingelheim allocates COVID relief fund to support underserved communities and patients in India
Boehringer Ingelheim is making available a Euro One Million COVID relief fund to support underserved communities and patients in India. Learn more here.
Webinars for clinicians on needs of vulnerable respiratory
Webinars with more than 1,000 HCPs to provide an update on prevention and treatment recommendations for vulnerable respiratory patients. Learn more here.
Oncology is a fast-moving, challenging field but with collaboration between different disciplines, we can develop the best practice care for our patients.
Atrial fibrillation (AF) is the most common cardiac rhythm disorder worldwide. Click here for more information on Stroke Prevention in atrial fibrillation.